CT-KIBRA improved synaptic plasticity and memory performance in a model of abnormal hyperacetylated tau, which is a common pathology found in most tauopathies, including AD, Pick’s disease, CBD, and PSP (2, 29, 57). The gene discussed is MAPT; the disease is Alzheimer disease.